{"entity":{"type":"insider","cik":"0001380710","url":"/insider/0001380710","json_url":"/insider/0001380710.json","name":"Davis George Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":129,"n_filings":76,"first":"2007-02-23","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Davis George Eric","source":"filing","n_filings":76,"first_seen":"2007-02-23","last_seen":"2026-02-26"}],"transactions":[{"id":5787111,"accession":"0001628280-26-012533","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-012533","line_url":"/filing/0001628280-26-012533#line-4","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26061.0,"shares_display":"26,061","price_per_share":61.36,"price_display":"61.36","price_state":"stated","total_value":1599102.96,"total_display":"1,599,102.96","total_whole":"1,599,103","shares_owned_after":72453.0,"shares_owned_after_display":"72,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-02-26","scope":"insider"},{"id":2751400,"accession":"0001048477-24-000112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001048477-24-000112","line_url":"/filing/0001048477-24-000112","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40850.0,"shares_display":"40,850","price_per_share":74.51166847001224,"price_display":"74.51","price_state":"stated","total_value":3043801.657,"total_display":"3,043,801.66","total_whole":"3,043,802","shares_owned_after":58936.0,"shares_owned_after_display":"58,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider","n_lines":2},{"id":2126620,"accession":"0001048477-24-000075","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001048477-24-000075","line_url":"/filing/0001048477-24-000075#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1850.0,"shares_display":"1,850","price_per_share":85.01,"price_display":"85.01","price_state":"stated","total_value":157268.5,"total_display":"157,268.50","total_whole":"157,269","shares_owned_after":56157.0,"shares_owned_after_display":"56,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-06","scope":"insider"},{"id":2211446,"accession":"0001048477-24-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-24-000054","line_url":"/filing/0001048477-24-000054#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24602.0,"shares_display":"24,602","price_per_share":88.34,"price_display":"88.34","price_state":"stated","total_value":2173340.68,"total_display":"2,173,340.68","total_whole":"2,173,341","shares_owned_after":55856.0,"shares_owned_after_display":"55,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":8600186,"accession":"0001048477-23-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-23-000059","line_url":"/filing/0001048477-23-000059#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13764.0,"shares_display":"13,764","price_per_share":95.3,"price_display":"95.30","price_state":"stated","total_value":1311709.2,"total_display":"1,311,709.20","total_whole":"1,311,709","shares_owned_after":55710.0,"shares_owned_after_display":"55,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider"},{"id":8577622,"accession":"0001048477-23-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-23-000033","line_url":"/filing/0001048477-23-000033#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":89.4238,"price_display":"89.42","price_state":"stated","total_value":983661.8,"total_display":"983,661.80","total_whole":"983,662","shares_owned_after":69474.0,"shares_owned_after_display":"69,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-09","scope":"insider"},{"id":6579609,"accession":"0001567619-22-015635","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-015635","line_url":"/filing/0001567619-22-015635","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51216.0,"shares_display":"51,216","price_per_share":95.95953959700094,"price_display":"95.96","price_state":"stated","total_value":4914663.78,"total_display":"4,914,663.78","total_whole":"4,914,664","shares_owned_after":55251.0,"shares_owned_after_display":"55,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-11","scope":"insider","n_lines":2},{"id":6687053,"accession":"0001567619-22-013886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013886","line_url":"/filing/0001567619-22-013886#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7398.0,"shares_display":"7,398","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":665820.0,"total_display":"665,820.00","total_whole":"665,820","shares_owned_after":58941.0,"shares_owned_after_display":"58,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-11","scope":"insider"},{"id":6376332,"accession":"0001567619-22-009494","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-009494","line_url":"/filing/0001567619-22-009494#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15347.0,"shares_display":"15,347","price_per_share":80.38,"price_display":"80.38","price_state":"stated","total_value":1233591.86,"total_display":"1,233,591.86","total_whole":"1,233,592","shares_owned_after":66339.0,"shares_owned_after_display":"66,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6355613,"accession":"0001567619-22-007415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-007415","line_url":"/filing/0001567619-22-007415#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6129.0,"shares_display":"6,129","price_per_share":81.29,"price_display":"81.29","price_state":"stated","total_value":498226.41,"total_display":"498,226.41","total_whole":"498,226","shares_owned_after":63329.0,"shares_owned_after_display":"63,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-23","scope":"insider"},{"id":4428246,"accession":"0001567619-21-014415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-014415","line_url":"/filing/0001567619-21-014415#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5518.0,"shares_display":"5,518","price_per_share":76.69,"price_display":"76.69","price_state":"stated","total_value":423175.42,"total_display":"423,175.42","total_whole":"423,175","shares_owned_after":58590.0,"shares_owned_after_display":"58,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":4943167,"accession":"0001567619-21-009021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-009021","line_url":"/filing/0001567619-21-009021","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4673.0,"shares_display":"4,673","price_per_share":78.3,"price_display":"78.30","price_state":"stated","total_value":365895.9,"total_display":"365,895.90","total_whole":"365,896","shares_owned_after":66197.0,"shares_owned_after_display":"66,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-04","scope":"insider","n_lines":2},{"id":4726721,"accession":"0001567619-21-008381","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-008381","line_url":"/filing/0001567619-21-008381#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2709.0,"shares_display":"2,709","price_per_share":79.58,"price_display":"79.58","price_state":"stated","total_value":215582.22,"total_display":"215,582.22","total_whole":"215,582","shares_owned_after":68440.0,"shares_owned_after_display":"68,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-20","scope":"insider"},{"id":2129599,"accession":"0001567619-20-008957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-008957","line_url":"/filing/0001567619-20-008957#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12504.0,"shares_display":"12,504","price_per_share":89.38,"price_display":"89.38","price_state":"stated","total_value":1117607.52,"total_display":"1,117,607.52","total_whole":"1,117,608","shares_owned_after":65677.0,"shares_owned_after_display":"65,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-01","filed_date":"2020-05-04","scope":"insider"},{"id":8171457,"accession":"0001567619-19-022384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-022384","line_url":"/filing/0001567619-19-022384#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3190.0,"shares_display":"3,190","price_per_share":79.66,"price_display":"79.66","price_state":"stated","total_value":254115.4,"total_display":"254,115.40","total_whole":"254,115","shares_owned_after":68709.0,"shares_owned_after_display":"68,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider"},{"id":8610144,"accession":"0001567619-19-007680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-007680","line_url":"/filing/0001567619-19-007680#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3363.0,"shares_display":"3,363","price_per_share":87.86,"price_display":"87.86","price_state":"stated","total_value":295473.18,"total_display":"295,473.18","total_whole":"295,473","shares_owned_after":71890.0,"shares_owned_after_display":"71,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-25","filed_date":"2019-03-26","scope":"insider"},{"id":8191313,"accession":"0001567619-19-007384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-007384","line_url":"/filing/0001567619-19-007384#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7907.0,"shares_display":"7,907","price_per_share":93.92,"price_display":"93.92","price_state":"stated","total_value":742625.44,"total_display":"742,625.44","total_whole":"742,625","shares_owned_after":78562.0,"shares_owned_after_display":"78,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider"},{"id":6166973,"accession":"0001567619-18-002824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-002824","line_url":"/filing/0001567619-18-002824","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2216.0,"shares_display":"2,216","price_per_share":99.452119133574,"price_display":"99.45","price_state":"stated","total_value":220385.896,"total_display":"220,385.90","total_whole":"220,386","shares_owned_after":73550.0,"shares_owned_after_display":"73,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-14","filed_date":"2018-09-18","scope":"insider","n_lines":3},{"id":6057317,"accession":"0001567619-18-002760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-002760","line_url":"/filing/0001567619-18-002760#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":99.57,"price_display":"99.57","price_state":"stated","total_value":1194840.0,"total_display":"1,194,840.00","total_whole":"1,194,840","shares_owned_after":74950.0,"shares_owned_after_display":"74,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-17","scope":"insider"},{"id":6025550,"accession":"0001140361-18-015281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-015281","line_url":"/filing/0001140361-18-015281#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3350.0,"shares_display":"3,350","price_per_share":81.35,"price_display":"81.35","price_state":"stated","total_value":272522.5,"total_display":"272,522.50","total_whole":"272,523","shares_owned_after":87989.0,"shares_owned_after_display":"87,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-27","scope":"insider"},{"id":6389956,"accession":"0001140361-18-014359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-014359","line_url":"/filing/0001140361-18-014359#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3818.0,"shares_display":"3,818","price_per_share":83.88,"price_display":"83.88","price_state":"stated","total_value":320253.84,"total_display":"320,253.84","total_whole":"320,254","shares_owned_after":94634.0,"shares_owned_after_display":"94,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-16","filed_date":"2018-03-20","scope":"insider"},{"id":6035432,"accession":"0001140361-18-012506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-012506","line_url":"/filing/0001140361-18-012506#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2105.0,"shares_display":"2,105","price_per_share":79.04,"price_display":"79.04","price_state":"stated","total_value":166379.2,"total_display":"166,379.20","total_whole":"166,379","shares_owned_after":90089.0,"shares_owned_after_display":"90,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-07","scope":"insider"},{"id":6051987,"accession":"0001140361-18-005181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-005181","line_url":"/filing/0001140361-18-005181#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":90.6555,"price_display":"90.66","price_state":"stated","total_value":2719665.0,"total_display":"2,719,665.00","total_whole":"2,719,665","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider"},{"id":4702766,"accession":"0001140361-17-044957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-044957","line_url":"/filing/0001140361-17-044957#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":85.639,"price_display":"85.64","price_state":"stated","total_value":102766.8,"total_display":"102,766.80","total_whole":"102,767","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":4818356,"accession":"0001140361-17-026335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-026335","line_url":"/filing/0001140361-17-026335#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9844.0,"shares_display":"9,844","price_per_share":96.6,"price_display":"96.60","price_state":"stated","total_value":950930.4,"total_display":"950,930.40","total_whole":"950,930","shares_owned_after":83581.0,"shares_owned_after_display":"83,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-23","filed_date":"2017-06-27","scope":"insider"},{"id":4615703,"accession":"0001140361-17-024414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-024414","line_url":"/filing/0001140361-17-024414#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9471.0,"shares_display":"9,471","price_per_share":91.039,"price_display":"91.04","price_state":"stated","total_value":862230.369,"total_display":"862,230.37","total_whole":"862,230","shares_owned_after":74342.0,"shares_owned_after_display":"74,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-07","scope":"insider"},{"id":4371987,"accession":"0001140361-17-019040","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-019040","line_url":"/filing/0001140361-17-019040#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":100.341,"price_display":"100.34","price_state":"stated","total_value":250852.5,"total_display":"250,852.50","total_whole":"250,853","shares_owned_after":85251.0,"shares_owned_after_display":"85,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-05","filed_date":"2017-05-09","scope":"insider"},{"id":5073843,"accession":"0001140361-17-012645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-012645","line_url":"/filing/0001140361-17-012645#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2238.0,"shares_display":"2,238","price_per_share":91.96,"price_display":"91.96","price_state":"stated","total_value":205806.48,"total_display":"205,806.48","total_whole":"205,806","shares_owned_after":73729.0,"shares_owned_after_display":"73,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-17","scope":"insider"},{"id":5178660,"accession":"0001140361-17-011077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-011077","line_url":"/filing/0001140361-17-011077#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1498.0,"shares_display":"1,498","price_per_share":93.32,"price_display":"93.32","price_state":"stated","total_value":139793.36,"total_display":"139,793.36","total_whole":"139,793","shares_owned_after":78962.0,"shares_owned_after_display":"78,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-06","filed_date":"2017-03-08","scope":"insider"},{"id":2745119,"accession":"0001140361-16-087654","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-087654","line_url":"/filing/0001140361-16-087654#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":90.42,"price_display":"90.42","price_state":"stated","total_value":452100.0,"total_display":"452,100.00","total_whole":"452,100","shares_owned_after":70798.0,"shares_owned_after_display":"70,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-22","scope":"insider"},{"id":2332032,"accession":"0001140361-16-074509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-074509","line_url":"/filing/0001140361-16-074509#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2167.0,"shares_display":"2,167","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":216700.0,"total_display":"216,700.00","total_whole":"216,700","shares_owned_after":71158.0,"shares_owned_after_display":"71,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":2154923,"accession":"0001140361-16-072219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-072219","line_url":"/filing/0001140361-16-072219#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2167.0,"shares_display":"2,167","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":195030.0,"total_display":"195,030.00","total_whole":"195,030","shares_owned_after":70669.0,"shares_owned_after_display":"70,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-07","filed_date":"2016-07-11","scope":"insider"},{"id":2523898,"accession":"0001140361-16-064404","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-16-064404","line_url":"/filing/0001140361-16-064404#line-4","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4658.0,"shares_display":"4,658","price_per_share":86.3202,"price_display":"86.32","price_state":"stated","total_value":402079.4916,"total_display":"402,079.49","total_whole":"402,079","shares_owned_after":75540.0,"shares_owned_after_display":"75,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-10","filed_date":"2016-05-10","scope":"insider"},{"id":2523887,"accession":"0001140361-16-064404","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-064404","line_url":"/filing/0001140361-16-064404#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":84.5532,"price_display":"84.55","price_state":"stated","total_value":845532.0,"total_display":"845,532.00","total_whole":"845,532","shares_owned_after":80198.0,"shares_owned_after_display":"80,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-09","filed_date":"2016-05-10","scope":"insider"},{"id":2563448,"accession":"0001140361-16-057973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-057973","line_url":"/filing/0001140361-16-057973#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1996.0,"shares_display":"1,996","price_per_share":86.212,"price_display":"86.21","price_state":"stated","total_value":172079.152,"total_display":"172,079.15","total_whole":"172,079","shares_owned_after":76190.0,"shares_owned_after_display":"76,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":8673050,"accession":"0001140361-15-044887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-044887","line_url":"/filing/0001140361-15-044887#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1362.0,"shares_display":"1,362","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":136200.0,"total_display":"136,200.00","total_whole":"136,200","shares_owned_after":66156.0,"shares_owned_after_display":"66,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-16","filed_date":"2015-12-17","scope":"insider"},{"id":8821130,"accession":"0001140361-15-020974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-020974","line_url":"/filing/0001140361-15-020974#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2558.0,"shares_display":"2,558","price_per_share":125.26,"price_display":"125.26","price_state":"stated","total_value":320415.08,"total_display":"320,415.08","total_whole":"320,415","shares_owned_after":69226.0,"shares_owned_after_display":"69,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-18","filed_date":"2015-05-19","scope":"insider"},{"id":8671810,"accession":"0001140361-15-012316","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-012316","line_url":"/filing/0001140361-15-012316#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":120.8668,"price_display":"120.87","price_state":"stated","total_value":1813002.0,"total_display":"1,813,002.00","total_whole":"1,813,002","shares_owned_after":73846.0,"shares_owned_after_display":"73,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-17","scope":"insider"},{"id":8671654,"accession":"0001140361-15-010309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-010309","line_url":"/filing/0001140361-15-010309#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":108.3055,"price_display":"108.31","price_state":"stated","total_value":2491026.5,"total_display":"2,491,026.50","total_whole":"2,491,027","shares_owned_after":64246.0,"shares_owned_after_display":"64,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":6529825,"accession":"0001140361-14-043679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-043679","line_url":"/filing/0001140361-14-043679#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":89.75,"price_display":"89.75","price_state":"stated","total_value":1795000.0,"total_display":"1,795,000.00","total_whole":"1,795,000","shares_owned_after":64426.0,"shares_owned_after_display":"64,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-28","scope":"insider"},{"id":7002292,"accession":"0001140361-14-039927","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-039927","line_url":"/filing/0001140361-14-039927#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":83.1953,"price_display":"83.20","price_state":"stated","total_value":1247929.5,"total_display":"1,247,929.50","total_whole":"1,247,930","shares_owned_after":64426.0,"shares_owned_after_display":"64,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-11-03","scope":"insider"},{"id":6804900,"accession":"0001140361-14-036353","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-036353","line_url":"/filing/0001140361-14-036353#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17536.0,"shares_display":"17,536","price_per_share":69.75,"price_display":"69.75","price_state":"stated","total_value":1223136.0,"total_display":"1,223,136.00","total_whole":"1,223,136","shares_owned_after":64426.0,"shares_owned_after_display":"64,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2014-09-23","scope":"insider"},{"id":6968362,"accession":"0001140361-14-009368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-009368","line_url":"/filing/0001140361-14-009368#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":1600000.0,"total_display":"1,600,000.00","total_whole":"1,600,000","shares_owned_after":60656.0,"shares_owned_after_display":"60,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-20","filed_date":"2014-02-24","scope":"insider"},{"id":4580868,"accession":"0001140361-13-020901","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-020901","line_url":"/filing/0001140361-13-020901#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":70.34,"price_display":"70.34","price_state":"stated","total_value":1406800.0,"total_display":"1,406,800.00","total_whole":"1,406,800","shares_owned_after":41708.0,"shares_owned_after_display":"41,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-15","scope":"insider"},{"id":5286441,"accession":"0001140361-13-020537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-020537","line_url":"/filing/0001140361-13-020537#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001380710","owner_name":"Davis George Eric","owner_display_name":"Davis George Eric","owner_url":"/insider/0001380710","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2590.0,"shares_display":"2,590","price_per_share":69.2865,"price_display":"69.29","price_state":"stated","total_value":179452.035,"total_display":"179,452.04","total_whole":"179,452","shares_owned_after":41708.0,"shares_owned_after_display":"41,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-13","filed_date":"2013-05-14","scope":"insider"}],"collapsed":true,"next_cursor":"2013-05-13|5286441","ledger_fault":false,"count":{"value":129,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":125,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":129},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (EVP, Chief Legal Officer)","n_filings":76,"first_seen":"2007-02-23","last_seen":"2026-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380710","retrieved_at":"2026-08-23T01:38:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}